Infection Surveillance Solutions Market Development And Business Intelligence
Seeking Alpha Analyst Since 2014
#Healthcare Consultant focusing on #TeleHealth #TeleMedicine #PatientPortals #CVIS #HCIT #MedicalRobots #Vaccines #MedicalDevices #WirelessHealth #Biotechnology
Summary
- Major factors influencing the growth of the market.
- Leading players & Business Strategies.
- Geographic Overview.
Market growth influenced due to following factors-
- Increasing incidence of hospital-acquired infections (HAIs) and new Medicare policies.
- Including non-payment for hospital-acquired conditions.
- The rising healthcare expenditure, increasing number of surgeries, growing geriatric population.
Global market size-
According to research report global infection surveillance solutions market is projected to reach USD 1,033 million by 2026 from USD 508 million in 2021, at a CAGR of 15.2%.
Leading Players-
The prominent players in the infection surveillance solutions market include Becton, Dickinson and Company (US), Premier International, Inc. (US), Wolters Kluwer N.V. (Netherlands), Cerner Corporation (US), Baxter International Inc. (US), GOJO Industries, Inc. (US), Sunquest (US), Deb Group Ltd. (UK), BioVigil Healthcare Systems (US), RLDatix (UK), IBM Corporation (US), Vecna Technologies, Inc. (US), VigiLanz Corporation (US), Ecolab Inc. (US), Harris Healthcare (US), PeraHealth Inc. (US), Medexter Healthcare (Austria), CenTrak, Inc. (US), bioMerieux SA (France), CKM Healthcare (Canada), Asolva Inc. (US), PointClickCare (Canada), STANLEY Healthcare (US), Vitalacy Inc. (US), and Vizzia Technologies (US).
For details Download PDF Brochure Here
Geographic Overview -
In 2020, North America accounted for the largest share of the infection surveillance solutions market, followed by Europe, the Asia Pacific, Latin America, and the Middle East & Africa.
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.